Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTAIN: Anticoagulation in Nephrotic Syndrome
NCT04850378Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Mar 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in nephrotic syndrome, sponsored by Aarhus University. Started Mar 2021; status: completed.
02
Drugs
apixaban
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT04850378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850378.